Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy

Eye Diseases Prevalence Research Group, 2004, Prevalence of age related macular degeneration in the United States, Arch Ophthalmol, 122, 564, 10.1001/archopht.122.4.564

Sato, 2004, Correlation of optical coherence tomography with angiography in retinal pigment epithelial detachment associated with age-related macular degeneration, Retina, 24, 910, 10.1097/00006982-200412000-00011

Poliner, 1986, Natural history of retinal pigment epithelial detachments in age-related macular degeneration, Ophthalmology, 93, 543, 10.1016/S0161-6420(86)33703-5

Gragoudas, 2004, Pegaptanib for neovascular age-related macular degeneration, N Engl J Med, 351, 2805, 10.1056/NEJMoa042760

Axer-Siegel, 2004, Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration, Arch Ophthalmol, 122, 453, 10.1001/archopht.122.4.453

Nicolo, 2005, Intravitreal triamcinolone in the treatment of serous pigment epithelial detachment and occult choroidal neovascularization secondary to agerelated macular degeneration, Eur J Ophthalmol, 15, 415, 10.1177/112067210501500318

Adamis, 2005, The role of vascular endothelial growth factor in ocular health and disease, Retina, 25, 111, 10.1097/00006982-200502000-00001

Ferrara, 2004, Vascular endothelial growth factor: basic science and clinical progress, Endocr Rev, 25, 581, 10.1210/er.2003-0027

Spaide, 2009, Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration, Am J Ophthalmol, 147, 644, 10.1016/j.ajo.2008.10.005

Lumbroso, 2011, Morphologic differences, according to etiology, in pigment epithelial detachments by means of en face optical coherence tomography, Retina, 31, 553, 10.1097/IAE.0b013e3181eef3eb

Chen, 2007, Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration, Retina, 27, 445, 10.1097/01.iae.0000249574.89437.40

Arora, 2011, One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration, Eye (Lond), 10.1038/eye.2011.115

Ach, 2010, Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration, Retina, 30, 1420, 10.1097/IAE.0b013e3181d87e97

Chakravarthy, 2012, Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial, Ophthalmology, 119, 1399, 10.1016/j.ophtha.2012.04.015

Clemens, 2012, High-resolution optical coherence tomography of subpigment epithelial structures in patients with pigment epithelium detachment secondary to age-related macular degeneration, Br J Ophthalmol, 96, 1088, 10.1136/bjophthalmol-2011-301415

Penha, 2012, Quantitative imaging of retinal pigment epithelial detachments using spectral-domain optical coherence tomography, Am J Ophthalmol, 153, 515, 10.1016/j.ajo.2011.08.031

Lee, 2012, Automated characterization of pigment epithelial detachment by OCT, Invest Ophthalmol Vis Sci, 53, 164, 10.1167/iovs.11-8188